Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases

OBJECTIVE: Dysfunction in fibroblast growth factor receptor (FGFR) signaling has been reported in diverse cancer types, including non-small cell lung cancer (NSCLC). The frequency of FGFR aberrations in Chinese NSCLC patients is therefore of great clinical significance. METHODS: A total of 10,966 NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhen, Liu, Zichuan, Ou, Qiuxiang, Wu, Xue, Wang, Xiaonan, Shao, Yang, Liu, Hongyan, Yang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185861/
https://www.ncbi.nlm.nih.gov/pubmed/33710807
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185861/
https://www.ncbi.nlm.nih.gov/pubmed/33710807
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0120

Ejemplares similares